Hypertension

Case Study: Diarrhea, Weight Loss Linked to Angiotensin Receptor Blocker

Case Study: Diarrhea, Weight Loss Linked to Angiotensin Receptor Blocker

By

A recently published report describes the case of a 59-year-old male patient who experienced olmesartan-associated enteropathy and highlights the importance of performing thorough medication reviews.

LDL-C Levels May Not Affect CVD Event Risk in Certain Patients With Hypertension

LDL-C Levels May Not Affect CVD Event Risk in Certain Patients With Hypertension

By

Researchers evaluated the relationship between low-density lipoprotein cholesterol and cardiovascular outcomes in patients with hypertension at increased cardiovascular risk.

High Prevalence of Hypertensive Crisis, Emergencies in Urban African-Americans

High Prevalence of Hypertensive Crisis, Emergencies in Urban African-Americans

The urban African-American population has a high prevalence of hypertensive crisis and hypertensive emergencies.

Intensive BP Treatment May Not Reduce Dementia Risk

Intensive BP Treatment May Not Reduce Dementia Risk

Treating systolic blood pressure (BP) to a goal of less than 120 mm Hg rather than 140 mm Hg does not result in a significant reduction in the risk for probable dementia.

Remote Hypertension Management Program Improves BP Control

Remote Hypertension Management Program Improves BP Control

A new home-based care delivery program can provide efficient and effective blood pressure control in individuals with hypertension.

FDA Provides Update on Ongoing Investigation Into Valsartan Products

FDA Provides Update on Ongoing Investigation Into Valsartan Products

By

The FDA has issued a statement regarding the ongoing investigation into potentially carcinogenic impurities identified in some angiotensin II receptor blockers.

Media Coverage of Expanded Definition of Hypertension Unbalanced

Media Coverage of Expanded Definition of Hypertension Unbalanced

By

Media coverage on the expanded definition of hypertension was largely positive but did not sufficiently cover information on potential harms.

Primary Hypertension May Not Affect Prognosis of Postmenopausal Osteoporosis

Primary Hypertension May Not Affect Prognosis of Postmenopausal Osteoporosis

By

The presence of primary hypertension does not appear to have an effect on the prognosis of postmenopausal osteoporosis.

FIRST-Metoprolol Unit-of-Use Compounding Kit Now Available

FIRST-Metoprolol Unit-of-Use Compounding Kit Now Available

By

Metoprolol tartrate is indicated for the treatment of hypertension, for the long-term treatment of angina pectoris, and for the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality.

Active CVD Screening Should Be Conducted in Comorbid COPD, Obesity

Active CVD Screening Should Be Conducted in Comorbid COPD, Obesity

By

Hypertension and diabetes are especially prevalent comorbidities in obese patients with chronic obstructive pulmonary disease.

FDA-Approved Wearable Blood Pressure Monitor, Medical App Now Available

FDA-Approved Wearable Blood Pressure Monitor, Medical App Now Available

By

HeartGuide is designed as a wrist watch that uses the oscillometric cuff method, the standard for medical-grade personal blood pressure measurement.

Modest But Consistent Systolic BP Reductions Achieved With Exercise

Modest But Consistent Systolic BP Reductions Achieved With Exercise

Exercise can consistently yield reductions in blood pressure.

Psoriasis Associated With Increased CV Intervention Risk in Patients With Hypertension

Psoriasis Associated With Increased CV Intervention Risk in Patients With Hypertension

Psoriasis is associated with an increased risk for cardiovascular interventions in patients with hypertension.

Correlates of Systolic BP Reduction After Liraglutide Treatment for Type 2 Diabetes

Correlates of Systolic BP Reduction After Liraglutide Treatment for Type 2 Diabetes

By

Patients with type 2 diabetes treated with liraglutide experience a greater reduction in systolic BP if they have lower baseline continuous glucose monitoring values and higher diastolic BP.

Updated Guidelines for Gestational Hypertension Released

Updated Guidelines for Gestational Hypertension Released

The ACOG has updated its guidance on the management of gestational hypertension and preeclampsia as well as chronic hypertension in pregnant women.

New BP Treatment Cutoffs May Not Yield Survival Benefit

New BP Treatment Cutoffs May Not Yield Survival Benefit

New blood pressure treatment recommendations may not improve survival from CVD.

Edentulism Tied to Greater Risk for High BP After Menopause

Edentulism Tied to Greater Risk for High BP After Menopause

Postmenopausal women with edentulism are at an increased risk for developing hypertension.

Considerable Benefits With Population Level Reduction of Sodium Intake

Considerable Benefits With Population Level Reduction of Sodium Intake

A considerable proportion of CVD deaths in Shandong Province, China, may be attributable to high sodium intake.

EHR Data Identifies Differences in HTN Control Across Health Systems

EHR Data Identifies Differences in HTN Control Across Health Systems

An analysis of electronic health record data reveals considerable differences in hypertension control across health systems.

Sustained Systolic Blood Pressure Reductions With Barbershop Intervention

Sustained Systolic Blood Pressure Reductions With Barbershop Intervention

A barbershop-based intervention can lead to significantly reduced blood pressure and sustained improvements over one year in black men.

Western Culture, Not Age, Linked to Elevated Blood Pressure

Western Culture, Not Age, Linked to Elevated Blood Pressure

By

Members of 2 remote Venezuelan tribes were found to have elevated blood pressure following exposure to Western culture.

New BP Targets Could Prevent 3 Million CVD Events Over 10 Years

New BP Targets Could Prevent 3 Million CVD Events Over 10 Years

Achieving and maintaining 2017 American College of Cardiology/American Heart Association (ACC/AHA) blood pressure (BP) goals could prevent a greater number of cardiovascular disease (CVD) events than achieving prior U.S. guideline goals.

Teva Recalls Additional Blood Pressure Medications

Teva Recalls Additional Blood Pressure Medications

All lots of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide combination blood pressure tablets have been recalled by Teva Pharmaceuticals.

Smoke-Free Policies Linked to Lower Systolic Blood Pressure

Smoke-Free Policies Linked to Lower Systolic Blood Pressure

Smoke-free policies are associated with small reductions in blood pressure.

Diuretic Regimen More Effectively Reduces CV Morbidity vs Telmisartan Combinations in Hypertension With Diabetes

Diuretic Regimen More Effectively Reduces CV Morbidity vs Telmisartan Combinations in Hypertension With Diabetes

By

Previous studies on the suitability of diuretics for patients with hypertension and diabetes reveal inconsistencies.

Calcium Channel Blockers May Reduce Peripheral Arterial Disease Risk in Hypertensive Patients

Calcium Channel Blockers May Reduce Peripheral Arterial Disease Risk in Hypertensive Patients

By

Meta-analysis suggests that calcium channel blockers can be effective in preventing peripheral arterial disease in patients with hypertension.

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

By

Combined treatment with pitavastatin and ezetimibe may be beneficial in patients with acute coronary syndrome and without hypertension for secondary prevention.

Additional Angiotensin Receptor Blocker Recalled Due to Presence of Probable Carcinogen

Additional Angiotensin Receptor Blocker Recalled Due to Presence of Probable Carcinogen

By

Sandoz announced a voluntary recall of 1 lot of Losartan Potassium and Hydrochlorothiazide Tablets 100mg/25mg due to trace amounts of NDEA found in the API losartan.

Does Antihypertensive Therapy Reduce CVD Risk in Low-Risk Patients With Mild Hypertension?

Does Antihypertensive Therapy Reduce CVD Risk in Low-Risk Patients With Mild Hypertension?

By

Treatment of low-risk patients presenting with mild hypertension with antihypertensive medication should be done with caution.

Case: Severe Acute Respiratory Distress Syndrome Following HCTZ Administration

Case: Severe Acute Respiratory Distress Syndrome Following HCTZ Administration

By

A recent report published in The Journal of Emergency Medicine describes the case of a male patient who experienced HCTZ-induced pulmonary edema that was complicated by ARDS.

Sign Up for Free e-Newsletters